In India, of the approximately 2.35 million people living with HIV (PLHIV), only 1.78 million know their status. , Important gains made in HIV testing nationwide have also been threatened over recent years, with people facing obstacles to accessing diagnostics during the pandemic. . Bridging India’s testing gap is essential to strengthen the nation’s infection response and help meet the UNAIDS’ first goal – to diagnose 95% of all HIV-positive patients, which can lead to effective treatment for those diagnosed, prompting viral suppression and an end to new HIV infections by 2030
Early and accurate detection of HIV positive patients is important to simplify the patient journey to access the needed care as quickly as possible. More so, it prevents future HIV transmissions, with individuals who are unaware of their infection 3.5 times more likely to transmit the virus to someone else. It also reduces the risk of patient morbidity and mortality.Dr.Ishwar Gilada, Consultant in HIV in Infectious Diseases, Unison Medicare and Research Centre Mumbai and President of AIDs Society of India,said, This facilitates timely treatment which can support better patient outcomes, while also curbing the spread of infection.”
Sunil Mehra, General Manager for Abbott’s Rapid Diagnostics business in India, commented, “Abbott is committed to scaling access of HIV diagnostic solutions to individuals at the point of care, ensuring fast and accurate results at critical points of infection. In India, we are supporting private and government hospitals and diagnostic centres with these next-generation tools to help address the country’s HIV burden.”
